<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection - Xia, Y - 2013 | Cochrane Library</title> <meta content="Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection - Xia, Y - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009004.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection - Xia, Y - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009004.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009004.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection" name="citation_title"/> <meta content="Yun Xia" name="citation_author"/> <meta content="Hui Luo" name="citation_author"/> <meta content="Beijing University of Chinese Medicine" name="citation_author_institution"/> <meta content="Jian Ping Liu" name="citation_author"/> <meta content="jianping_l@hotmail.com" name="citation_author_email"/> <meta content="Christian Gluud" name="citation_author"/> <meta content="Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD009004.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/04/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009004.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009004.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009004.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antiviral Agents [*therapeutic use]; Hepatitis B e Antigens [blood]; Hepatitis B virus [immunology]; Hepatitis B, Chronic [*drug therapy, immunology]; Interferon-alpha [therapeutic use]; Lamivudine [therapeutic use]; *Phyllanthus; *Phytotherapy; Randomized Controlled Trials as Topic; Thymalfasin; Thymosin [analogs &amp; derivatives, therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009004.pub2&amp;doi=10.1002/14651858.CD009004.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WbpyPs9C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009004\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009004\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ja","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009004.pub2",title:"Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection",firstPublishedDate:"Apr 30, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hepato‐Biliary Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009004.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009004.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009004.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009004.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009004.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009004.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009004.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009004.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009004.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009004.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1150 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009004.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-sec1-0005"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/appendices#CD009004-sec1-0011"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/table_n/CD009004StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/table_n/CD009004StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information#CD009004-cr-0002">Yun Xia</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information#CD009004-cr-0003">Hui Luo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information#CD009004-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Jian Ping Liu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information#CD009004-cr-0005">Christian Gluud</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information/en#CD009004-sec1-0013">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 April 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009004.pub2">https://doi.org/10.1002/14651858.CD009004.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009004-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009004-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009004-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009004-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009004-abs-0002">日本語</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009004-abs-0001" lang="en"> <section id="CD009004-abs1-0001"> <h3 class="title" id="CD009004-abs1-0001">Background</h3> <p><i>Phyllanthus</i> species for patients with chronic hepatitis B virus (HBV) infection have been assessed in clinical trials, but no consensus regarding their usefulness exists. When compared with placebo or no intervention, we were unable to identify convincing evidence that <i>phyllanthus</i> species are beneficial in patients with chronic hepatitis B. Some randomised clinical trials have compared <i>phyllanthus</i> species versus antiviral drugs. </p> </section> <section id="CD009004-abs1-0002"> <h3 class="title" id="CD009004-abs1-0002">Objectives</h3> <p>To evaluate the benefits and harms of <i>phyllanthus</i> species compared with antiviral drugs for patients with chronic HBV infection. </p> </section> <section id="CD009004-abs1-0003"> <h3 class="title" id="CD009004-abs1-0003">Search methods</h3> <p>Searches were performed in The Cochrane Hepato‐Biliary Gorup Controlled Trials Register, The Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i>, MEDLINE, EMBASE, Science Citation Index Expended, and the Chinese Biomedical CD Database, China Network Knowledge Information, Chinese Science Journal Database, TCM Online, and Wanfang Database. Conference proceedings in Chinese were handsearched. All searches were conducted until 31st October 2012. </p> </section> <section id="CD009004-abs1-0004"> <h3 class="title" id="CD009004-abs1-0004">Selection criteria</h3> <p>Randomised clinical trials comparing <i>phyllanthus</i> species with antiviral drugs for patients with chronic HBV infection. We included trials irrespective of blinding, publication status, or language. </p> </section> <section id="CD009004-abs1-0005"> <h3 class="title" id="CD009004-abs1-0005">Data collection and analysis</h3> <p>Two authors selected the trials and extracted the data independently. The RevMan software was used for statistical analysis of dichotomous data with risk ratio (RR) with 95% confidence intervals (CI). We assessed the risk of bias to control for systematic errors. We calculated the number of patients needed (required information size) to be randomised in order to make reliable conclusions. We assessed the cumulative findings with trial sequential analysis to control for random errors. </p> </section> <section id="CD009004-abs1-0006"> <h3 class="title" id="CD009004-abs1-0006">Main results</h3> <p>We identified five randomised clinical trials with 290 patients. All trials were considered to have high risk of bias. Patients in the experimental group received compound <i>phyllanthus</i> for three months to 12 months. Patients in the antiviral drug group received lamivudine, interferon alpha, thymosin, or thymosin alpha 1. None of the trials reported mortality, hepatitis B‐related morbidity, quality of life, or liver histology. <i>Phyllanthus</i> seemed to have a superior effect on clearance of serum HBeAg at the end of treatment in conventional meta‐analysis (RR 0.76; 95% CI 0.64 to 0.91, P = 0.002; I<sup>2</sup> = 0%), but not when trial sequential analysis was applied. <i>Phyllanthus</i> had no significant effect on clearance of serum HBsAg (RR 1.00; 95% CI 0.93 to 1.08, P = 0.92; I<sup>2</sup> = 0%) or HBV DNA (RR 0.83; 95% CI 0.53 to 1.31, P = 0.43; I<sup>2</sup> = 70%) when compared with antiviral drugs. Data on HBeAg seroconversion was reported in one trial and no significant difference was found comparing <i>phyllanthus</i> versus lamivudine (RR 0.89; 95% CI 0.71 to 1.11). No data were reported on adverse events in the five trials. </p> </section> <section id="CD009004-abs1-0007"> <h3 class="title" id="CD009004-abs1-0007">Authors' conclusions</h3> <p>There is currently insufficient evidence to support or refute the use of <i>phyllanthus</i> for patients with chronic hepatitis B virus infection. Researchers who are interested in conducting further randomised clinical trials on <i>phyllanthus</i> ought to monitor both beneficial and harmful effects and should primarily test the herb against placebo in addition to antiviral drugs that are known to offer more benefit than harm. Only in this way new interventions can be assessed without compromising personal ethical considerations. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009004-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009004-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009004-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009004-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009004-abs-0006">日本語</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009004-abs-0005" lang="en"> <h3>Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection</h3> <p>Chronic hepatitis B virus (HBV) infection causes significant mortality, morbidity, and it is an economic burden worldwide. Although the current approved therapies show beneficial effects, response to treatment is not satisfactory, patients are at high risk of developing viral resistance, and serious adverse events occur. The objective of this review was to evaluate the benefits and harms of <i>phyllanthus</i> species compared with commonly used antiviral drugs for patients with chronic HBV infection. In a previous Cochrane Hepato‐Biliary Group systematic review we have compared <i>phyllanthus</i> species versus placebo or no intervention. In that review, we were unable to find convincing evidence to support the use of <i>phyllanthus</i> species for patients with chronic hepatitis B. </p> <p>The findings of this review are based on five randomised clinical trials with 290 patients. <i>Phyllanthus</i> was tested versus antiviral drugs, including lamivudine, interferon alpha, thymosin, or thymosin alpha 1 for three months to 12 months. The primary findings of this review are that <i>phyllanthus</i> seemed to have a superior effect on clearance of serum HBeAg at the end of treatment in conventional meta‐analysis, but not when trial sequential analysis was applied. <i>Phyllanthus</i> had no significant effect on clearance of serum HBsAg, serum HBV DNA, or HBeAg seroconversion when compared with antiviral drugs. No data were identified on mortality or morbidity, adverse events, quality of life, or liver histology. However, the findings in our review are inconclusive due to the small numbers of patients and outcomes, risk of bias, and the study design. We need more randomised trials to confirm or reject the potential effects of <i>phyllanthus</i> . We advocate that <i>phyllanthus</i> is primarily assessed against placebo. This can be done in randomised clinical trials in which all patients receive antiviral drugs that are known to offer more benefit than harm and the patients are then randomised to <i>phyllanthus</i> versus placebo. If the effect of <i>phyllanthus</i> versus placebo is unequivocally demonstrated in such trials, it may be prudent to assess the effects of <i>phyllanthus</i> versus other antiviral drugs superior to placebo in such trials. The quality of trials regarding conduct and report should also be taken into account. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009004-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009004-sec1-0006"></div> <h3 class="title" id="CD009004-sec1-0007">Implications for practice</h3> <section id="CD009004-sec1-0007"> <p>There is insufficient evidence from randomised trials to support or refute the use of <i>phyllanthus</i> for patients with chronic hepatitis B virus infection. There is no conclusive evidence of benefit due to the limited number of trials conducted, the small number of patients and outcomes, the design and the risk of bias of included trials, and the insufficient power to provide robust conclusions. </p> </section> <h3 class="title" id="CD009004-sec1-0008">Implications for research</h3> <section id="CD009004-sec1-0008"> <p>The reviewed results of the five clinical trials do not show firm evidence for a beneficial effect of <i>phyllanthus</i> . However, due to the small number of trials and few patients included, further trials may be considered. If such trials are performed, then both beneficial and harmful effects ought to be monitored and reported. It will also be necessary to report the species and preparations of <i>phyllanthus</i>. Any further trials should contain enough patients in accordance with the sample size estimation, primary outcome measures closely relevant to patients, and long‐term follow up to observe potential improvement in liver histology. Future trials ought to be reported according to the Consort Statement (www.consort‐statement.org). </p> <p>The choice of the control treatment in a clinical trial should be justified, and methodological and ethical arguments should be taken into account. When no final conclusion can be reached due to the study design, it is not ethically no acceptable to perform the trial. We advocate that <i>phyllanthus</i> is primarily assessed against placebo. This can be done in randomised clinical trials in which all patients received antiviral drugs that are known to offer more benefit than harm and the patients are then randomised to <i>phyllanthus</i> versus placebo (the so called 'add‐on' trials). Only when the effect of <i>phyllanthus</i> is unequivocally demonstrated as superior to placebo, it is prudent to assess the effects of <i>phyllanthus</i> versus other antiviral drugs superior to placebo in future randomised clinical trials (<a href="./references#CD009004-bbs2-0072" title="ScaglioneSJ , LokASF . Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology2012;142(6):1360‐8. ">Scaglione 2012</a>). </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009004-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009004-sec1-0001"></div> <section id="CD009004-sec2-0001"> <h3 class="title" id="CD009004-sec2-0001">Description of the condition</h3> <p>Chronic hepatitis B virus (HBV) infection is one of the most common infectious diseases in the world and may cause cirrhosis, hepatocellular carcinoma, and death. World‐wide, hepatitis B virus causes more than one million deaths every year, and more than 350 million people are chronically infected (<a href="./references#CD009004-bbs2-0082" title="World Health Organization. Viral hepatitis. Report by the secretariat. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_15‐en.pdf(accessed January 2010). ">WHO 2010</a>). This constitutes a significant health and economic burden. In China, the HBV infection is highly endemic. It is estimated in China that there are 120 million chronically infected carriers; up to 12 million people suffer from chronic hepatitis B, and about 300,000 people die each year (<a href="./references#CD009004-bbs2-0075" title="SunJ , HouJL . Management of chronic hepatitis B: experience from China. Journal of Viral Hepatitis2010;17(1):10‐7. ">Sun 2010</a>). A study has shown that the total economic loss resulting from chronic hepatitis B‐associated disease was probably in the range of US$ 8.5 to 15.6 billion in year 2001 (<a href="./references#CD009004-bbs2-0074" title="ShiG , XieYF , LiuXY . Estimation of economic burden of hepatitis B. Chinese Primary Health2004;8:18‐9. ">Shi 2004</a>; <a href="./references#CD009004-bbs2-0045" title="HuM , ChenW . Assessment of total economic burden of chronic hepatitis B‐related disease in Beijing and Guangzhou, China. Value in Health2009;12(3):89‐92. ">Hu 2009</a>). </p> <p>There is a hepatitis B vaccine available, and the vaccine is found to be 95% effective in preventing HBV infection (<a href="./references#CD009004-bbs2-0034" title="ChenW , GluudC . Vaccines for preventing hepatitis B in health‐care workers. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD000100.pub3] ">Chen 2005</a>; <a href="./references#CD009004-bbs2-0053" title="LeeC , GongY , BrokJ , BoxallEH , GluudC . Hepatitis B immunisation for newborn infants of hepatitis B surface antigen‐positive mothers. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD004790.pub2] ">Lee 2006</a>; <a href="./references#CD009004-bbs2-0063" title="MathewJL , ElDibR , MathewPJ , BoxallEH , BrokJ . Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD006481.pub2] ">Mathew 2008</a>; <a href="./references#CD009004-bbs2-0081" title="WHO2008 . Hepatitis B. World Health Organization Fact Sheet 204 (Revised August 2008). http://www.who.int/mediacentre/factsheets/fs204/en/index.html 2008 (accessed 26 October 2010). ">WHO 2008</a>). Most countries have included the hepatitis B vaccine into their national infant immunisation programmes, and vaccination has markedly reduced the frequency of chronic HBV infection (<a href="./references#CD009004-bbs2-0033" title="ChangMH , ChenCJ , LaiMS , HsuHM , WuTC , KongMS , et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New England Journal of Medicine1997;336(26):1855‐9. ">Chang 1997</a>; <a href="./references#CD009004-bbs2-0080" title="WHO2001 . Introduction of hepatitis B vaccine into childhood immunization services. Management guidelines, including information for health workers and parents. www.who.int/vaccines‐documents/DocsPDF01/www613.pdf 2001 (accessed 26 October 2010). ">WHO 2001</a>). Furthermore, hepatitis B vaccine has been shown to be cost‐effective (<a href="./references#CD009004-bbs2-0027" title="AggarwalR , GhoshalUC , NaikSR . Assessment of cost‐effectiveness of universal hepatitis B immunization in a low‐income country with intermediate endemicity using a Markov model. Journal of Hepatology2003;38(2):215‐22. ">Aggarwal 2003</a>). However, vaccination offers no benefit for adults with chronic HBV infection. Hence, millions of patients are awaiting improvement in the treatment of this disease. </p> </section> <section id="CD009004-sec2-0002"> <h3 class="title" id="CD009004-sec2-0002">Description of the intervention</h3> <p>Currently approved therapies for chronic hepatitis B include immunomodulatory agents (interferon alpha and pegylated interferon alpha) and nucleoside analogues (lamivudine, telbivudine, entecavir, adefovir, and tenofovir) (<a href="./references#CD009004-bbs2-0039" title="European Association for the Study of the Liver. EASL Clinical Practice Guidellines: Management of chronic hepatitis B. Journal of Hepatology2009; Vol. 50, issue 2:227‐42. ">EASL 2009</a>). Interferon alpha treatment results in viral, biochemical, and histological remission in about 30% of the patients (<a href="./references#CD009004-bbs2-0039" title="European Association for the Study of the Liver. EASL Clinical Practice Guidellines: Management of chronic hepatitis B. Journal of Hepatology2009; Vol. 50, issue 2:227‐42. ">EASL 2009</a>). However, interferon alpha (conventional or pegylated) has the disadvantages of high cost and serious adverse events, which may lead to treatment discontinuation. Lamivudine is inexpensive, but patients are at high risk of developing viral resistance. New antiviral drugs characterised by more potent antiviral effects, less toxicity, and minimal risk of resistance have been explored during the past decades. Entecavir and tenofovir are potent HBV inhibitors and have a high barrier to resistance (<a href="./references#CD009004-bbs2-0039" title="European Association for the Study of the Liver. EASL Clinical Practice Guidellines: Management of chronic hepatitis B. Journal of Hepatology2009; Vol. 50, issue 2:227‐42. ">EASL 2009</a>). Adefovir has most of the advantages of lamivudine, with the additional benefit that viral drug resistance is uncommon (<a href="./references#CD009004-bbs2-0062" title="MarcellinP , ChangTT , LimSG , TongMJ , SievertW , ShiffmanML . Adefovir dipivoxil for the treatment of hepatitis B e antigen‐positive chronic hepatitis B. New England Journal of Medicine2003;348:808‐16. ">Marcellin 2003</a>). Telbivudine is another potent inhibitor of HBV (<a href="./references#CD009004-bbs2-0039" title="European Association for the Study of the Liver. EASL Clinical Practice Guidellines: Management of chronic hepatitis B. Journal of Hepatology2009; Vol. 50, issue 2:227‐42. ">EASL 2009</a>). However, despite these advances, the use of these drugs may still be limited by cost, and by being effective in a limited number of patients only. In China, a large number of patients who cannot afford this 'standard therapy' seek help from traditional Chinese medicine. </p> <p><i>Phyllanthus</i> is the largest genus in <i>Phyllanthaceae</i> (<a href="./references#CD009004-bbs2-0048" title="KathriarachchiH , HoffmannP , SamuelR , WurdackKJ , ChaseMW . Molecular phylogenetics of phyllanthaceae inferred from five genes. Molecular Phylogenetics and Evolution2005;36(1):112‐34. ">Kathriarachchi 2005</a>). The plants are widely distributed in most tropical and subtropical countries, and it is estimated that there are over 1200 species in the world (<a href="./references#CD009004-bbs2-0048" title="KathriarachchiH , HoffmannP , SamuelR , WurdackKJ , ChaseMW . Molecular phylogenetics of phyllanthaceae inferred from five genes. Molecular Phylogenetics and Evolution2005;36(1):112‐34. ">Kathriarachchi 2005</a>). The plants of <i>phyllanthus</i> species are considered bitter, astringent, stomachic, diuretic, febrifuge, deobstruent, and antiseptic and have long been used in traditional Chinese medicine to treat chronic liver diseases (<a href="./references#CD009004-bbs2-0031" title="CalixtoJB , SantosARS , FilboVC , YunesRA . A review of the plants of the genus phyllanthus: their chemistry, pharmacology, and therapeutic potential. Medical Research Review1998;18(4):225‐58. ">Calixto 1998</a>). Studies carried out on extracts and main constituents that are isolated from different species of <i>phyllanthus,</i> seems to support most of the reported usages in folk medicine defining them as effective antiviral agents and hepatoprotective agents (<a href="./references#CD009004-bbs2-0028" title="BagalkotkarG , SagineeduSR , SaadMS , StanslasJ . Phytochemicals from phyllanthus niruri Linn and their pharmacological properties: a review. Journal of Pharmacy and Pharmacology2006;58(12):1559‐70. ">Bagalkotkar 2006</a>; <a href="./references#CD009004-bbs2-0049" title="KhatoonS , RaiV , RawatAK , MehrotraS . Comparative pharmacognostic studies of three Phyllanthus species. Journal of Ethnopharmacology2006;104(1‐2):79‐86. ">Khatoon 2006</a>; <a href="./references#CD009004-bbs2-0051" title="LamWY , LeungKT , LawPT , LeeSM , ChanHL , FungKP , et al. Antiviral effect of phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis. Journal of Cellular Biochemistry2006;97(4):795‐812. ">Lam 2006</a>). In China, <i>phyllanthus</i> was added to the Pharmacopoeia of People's Republic of China in 1992, and subsequent clinical studies seem to have proven the therapeutic effects of <i>phyllanthus</i> for chronic hepatitis B virus infection (<a href="./references#CD009004-bbs2-0032" title="ChangCW , LinMT , LeeSS , LiuKC , HsuFL , LinJY . Differential inhibition of reverse transcriptase and cellular DNA polymerase‐alpha activities by Lignans isolated from Chinese herbs, phyllanthus Myrtifolius Moon, and tannins from Lonicera Japonica Thunb and Castanopsis hystrix. Antiviral Research1995;27(4):367‐74. ">Chang 1995</a>). </p> </section> <section id="CD009004-sec2-0003"> <h3 class="title" id="CD009004-sec2-0003">How the intervention might work</h3> <p>Substantial progress on the chemical and pharmacological properties of <i>phyllanthus</i> species has been made (<a href="./references#CD009004-bbs2-0031" title="CalixtoJB , SantosARS , FilboVC , YunesRA . A review of the plants of the genus phyllanthus: their chemistry, pharmacology, and therapeutic potential. Medical Research Review1998;18(4):225‐58. ">Calixto 1998</a>). Phytochemical studies carried out on these plants isolate have characterised a number of classes of compounds, including alkaloids, flavonoids, lignans, phenols, tannins, coumarins, and terpenes (<a href="./references#CD009004-bbs2-0077" title="VenateswaranPS , MillmanI , BlumbergBS . Effects of an extract from phyllanthus niruri on hepatitis B virus and woodchuck hepatitis viruses: in vitro and in vivo studies. Proceedings of the National Academy of Sciences1987;84(1):274‐8. ">Venateswaran 1987</a>). These compounds seem to be mainly responsible for the pharmacological actions reported in relation to these plants. Most of these compounds were found to interact with most key enzymes, such as aldose reductase, angiotensin converting enzyme, mitochondrial ATPase, both cyclooxygenase and lipoxygenase, phospholipase A2, tyrosine kinase, reverse transcriptase, and phosphodiesterases (<a href="./references#CD009004-bbs2-0032" title="ChangCW , LinMT , LeeSS , LiuKC , HsuFL , LinJY . Differential inhibition of reverse transcriptase and cellular DNA polymerase‐alpha activities by Lignans isolated from Chinese herbs, phyllanthus Myrtifolius Moon, and tannins from Lonicera Japonica Thunb and Castanopsis hystrix. Antiviral Research1995;27(4):367‐74. ">Chang 1995</a>; <a href="./references#CD009004-bbs2-0029" title="BlumbergBS . Hepatitis B virus: search for plant‐derived antiviral. In: TomlinsonTR , AkereleD editor(s). Medical Plants ‐ Their Role in Health and Biodiversity. Philadelphia: University of Pennsylvania Press, 1998:7. ">Blumberg 1998</a>). Many studies suggest that most plants of the <i>phyllanthus</i> species have a beneficial effect against HBV in vitro and in vivo (<a href="./references#CD009004-bbs2-0058" title="LiuZ , FuX , ZhangN , ZhangG , LiuD . The inhibitory effect of Chinese herb Phyllanthus on hepatitis B virus in vitro. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi1997;11(3):282‐5. ">Liu 1997</a>), possibly through inhibition of polymerase activity, mRNA transcription, and replication (<a href="./references#CD009004-bbs2-0077" title="VenateswaranPS , MillmanI , BlumbergBS . Effects of an extract from phyllanthus niruri on hepatitis B virus and woodchuck hepatitis viruses: in vitro and in vivo studies. Proceedings of the National Academy of Sciences1987;84(1):274‐8. ">Venateswaran 1987</a>; <a href="./references#CD009004-bbs2-0032" title="ChangCW , LinMT , LeeSS , LiuKC , HsuFL , LinJY . Differential inhibition of reverse transcriptase and cellular DNA polymerase‐alpha activities by Lignans isolated from Chinese herbs, phyllanthus Myrtifolius Moon, and tannins from Lonicera Japonica Thunb and Castanopsis hystrix. Antiviral Research1995;27(4):367‐74. ">Chang 1995</a>; <a href="./references#CD009004-bbs2-0052" title="LeeCD , OttM , ThyagarajanSP , ShafritzDA , BurkRD , GuptaS . Phyllanthus amarus down‐regulates hepatitis B virus mRNA transcription and replication. European Journal of Clinical Investigation1996;26(12):1069‐76. ">Lee 1996</a>; <a href="./references#CD009004-bbs2-0066" title="OttM , ThyagarajanSP , GuptaS . Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors. European Journal of Clinical Investigation1997;27(11):908‐15. ">Ott 1997</a>). </p> </section> <section id="CD009004-sec2-0004"> <h3 class="title" id="CD009004-sec2-0004">Why it is important to do this review</h3> <p>A systematic review about genus <i>phyllanthus</i> for chronic hepatitis B virus infection showed potential effect on the clearance of serum HBsAg, HBeAg, HBV DNA, and on liver enzymes normalisation, as well as a better effect of the <i>phyllanthus</i> plus interferon alpha combination than interferon alpha alone on clearance of serum HBeAg and HBV DNA (<a href="./references#CD009004-bbs2-0059" title="LiuJP , LinH , McIntoshH . Genus Phyllanthus for chronic hepatitis B virus infections: a systematic review. Journal of Viral Hepatitis2001;8:358‐66. ">Liu 2001</a>). However, due to the limitations of the clinical trials included in that review (small number of patients and high risk of bias the included trials), there is currently still no strong evidence available on <i>phyllanthus</i> species for chronic hepatitis B. We recently reviewed systematically the randomised trials comparing <i>phyllanthus</i> species versus placebo or no intervention for patients with chronic hepatitis B and we did not find any high quality evidence to support <i>phyllanthus</i> species (<a href="./references#CD009004-bbs2-0084" title="XiaY , LuoH , LiuJP , GluudC . Phyllanthus species for chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews2011, Issue 4. [DOI: 10.1002/14651858.CD008960.pub2] ">Xia 2011</a>). During the past several years, more clinical trials have been carried out comparing <i>phyllanthus</i> versus antiviral drugs for chronic hepatitis B. We have been unable to identify any meta‐analyses or systematic reviews assessing <i>phyllanthus</i> versus antiviral drugs in chronic hepatitis B. Current uncertainties about the clinical effectiveness of <i>phyllanthus</i> species require a Cochrane systematic review to clarify the potential benefits and harms in the treatment of chronic hepatitis B. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009004-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009004-sec1-0002"></div> <p>To evaluate the benefits and harms of <i>phyllanthus</i> species compared with antiviral drugs for patients with chronic HBV infection. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009004-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009004-sec1-0003"></div> <section id="CD009004-sec2-0005"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009004-sec3-0001"> <h4 class="title">Types of studies</h4> <p>We included randomised clinical trials irrespective of publication status, language, or blinding. We excluded studies using alternation, date of birth, hospital record number, or other 'quasi‐random' methods of allocation of treatment, except for the assessment of harms. </p> </section> <section id="CD009004-sec3-0002"> <h4 class="title">Types of participants</h4> <p>We included participants with chronic HBV infection. Patients with chronic HBV infection were divided into HBeAg positive and HBeAg negative according to HBeAg blood test. We used the definition of chronic HBV infection of the individual trials. If in doubt which type of chronic hepatitis B infection (HBeAg positive or negative) the patient had, we used the following definitions, based on <a href="./references#CD009004-bbs2-0060" title="LokAS , McMahonBJ . Chronic hepatitis B. Hepatology2009;50(3):661‐2. ">Lok 2009</a>: </p> <p> <ul id="CD009004-lst1-0001"> <li> <p>HBeAg‐positive chronic hepatitis B infection defined as HBsAg and HBeAg positivity for more than six months, serum HBV DNA usually positivity more than 20,000 IU/ml, ie, 10<sup>5</sup>copies/ml, persistent or intermittent elevation in levels of aspartate aminotransferase or alanine aminotransferase, and liver biopsy findings showing moderate or severe necroinflammation compatible with with chronic hepatitis B. </p> </li> </ul> <ul id="CD009004-lst1-0002"> <li> <p>HBeAg‐negative chronic hepatitis B infection defined as HBsAg positivity for more than six months without HBeAg positivity, serum HBV DNA positivity usually between 2000 to 20,000 IU/ml, ie, 10<sup>4</sup> to 10<sup>5</sup> copies/ml, and persistent or intermittent elevation in activity of aspartate aminotransferase or alanine aminotransferase, and liver biopsy findings showing moderate or severe necroinflammation compatible with chronic hepatitis B. </p> </li> </ul> </p> <p>We included trials with both children and adult participants. For the purpose of this review we defined a child as aged 15 years or less and an adult as aged 16 years or older. We planned to include patients irrespective of whether they were treatment‐naive or had previously been treated unsuccessfully for chronic HBV infection with another drug. We planned to include patients with evidence of concomitant HIV infection, hepatitis C, hepatitis D, hepatocellular carcinoma, or other liver related co‐morbidities, but we analysed the patients with and without these conditions also separately. We also planned to include patients with prior liver transplantation or with concomitant renal failure but again analysed these patients groups separately. </p> </section> <section id="CD009004-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>We considered trials eligible for inclusion if they assessed any single medicinal herb belonging to the plant species <i>phyllanthus</i> or any other compound from the plant species <i>phyllanthus</i> versus antiviral drugs, including interferon, nucleoside analogues, or immunomodulating agents. The plant species <i>phyllanthus</i> should have been the only active constituent in the experimental compound, but other ingredients assumed to have no antiviral effects may be added to the <i>phyllanthus</i> species (so‐called compound <i>phyllanthus</i>). </p> <p>We did not consider trials for inclusion if they used decoctions prepared with <i>phyllanthus</i>. </p> </section> <section id="CD009004-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <p>The following outcome measures were sought at the end of treatment as well as at maximal follow‐up. </p> <section id="CD009004-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009004-lst1-0003"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Hepatitis B‐related mortality (caused by morbidities or decompensation of the liver such as liver cirrhosis or hepatocellular carcinoma). </p> </li> <li> <p>Hepatitis B‐related morbidity (decompensation of the liver such as liver cirrhosis or hepatocellular carcinoma). </p> </li> <li> <p>Number of participants with serious and non‐serious adverse events in separate (as defined by the International Conference on Harmonisation Guideline for Good Clinical Practice (<a href="./references#CD009004-bbs2-0046" title="International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR &amp; ICH Guidelines. Vol. 1, PA 19063‐2043, USA: Barnett International/PAREXEL, 1997. ">ICH‐GCP 1997</a>)). </p> </li> <li> <p>Quality of life (as defined by the trialists).</p> </li> </ol> </p> </section> <section id="CD009004-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD009004-lst1-0004"> <li> <p>Number of participants with detectable serum HBsAg.</p> </li> <li> <p>Number of participants with detectable serum HBV DNA.</p> </li> <li> <p>Number of participants with detectable serum HBeAg (this outcome measure is not relevant for the HBeAg‐negative participants). </p> </li> <li> <p>Number of participants without HBeAg seroconversion (this outcome measure is not relevant for the HBeAg‐negative participants). </p> </li> <li> <p>Number of participants with worsened liver histology.</p> </li> </ol> </p> </section> </section> </section> <section id="CD009004-sec2-0006"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009004-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>We identified trials by electronic searches of The Cochrane Hepato‐Biliary Group Controlled Trials Register <i>(</i><a href="./references#CD009004-bbs2-0042" title="GluudC , NikolovaD , KlingenbergSL , AlexakisN , Als‐NielsenB , ColliA , et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2011, Issue 8. Art. No.: LIVER. ">Gluud 2011</a>), The Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i>, MEDLINE, EMBASE, Science Citation Index Expended (<a href="./references#CD009004-bbs2-0068" title="RoyleP , MilneR . Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care2003;19(4):591‐603. ">Royle 2003</a>), and the Chinese Biomedical CD Database (CBM), China Network Knowledge Information (CNKI), Chinese Science Journal Database (VIP), TCM Online, and Wanfang Database. All the databases above were searched from their date of inception onwards until October 31, 2012 and irrespective of language or publication status. </p> <p>The preliminary search strategies with the expected time span of the searches have been given in <a href="./appendices#CD009004-sec2-0012">Appendix 1</a>. </p> </section> <section id="CD009004-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>Conference proceedings in Chinese were handsearched. We screened the reference lists of all retrieved randomised trials and review articles for eligible trials. </p> </section> </section> <section id="CD009004-sec2-0007"> <h3 class="title" id="CD009004-sec2-0007">Data collection and analysis</h3> <p>The methodology for data collection and analysis is based on The <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD009004-bbs2-0044" title="HigginsJ , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Colloboration, 2009. Available from www.cochrane‐handbook.org. ">Higgins 2009</a>) and the <i>Cochrane Hepato‐Biliary Group Module</i> (<a href="./references#CD009004-bbs2-0042" title="GluudC , NikolovaD , KlingenbergSL , AlexakisN , Als‐NielsenB , ColliA , et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2011, Issue 8. Art. No.: LIVER. ">Gluud 2011</a>). </p> <section id="CD009004-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>Two authors (YX and HL) independently screened the titles and abstracts of studies identified by the literature search for eligibility according to the prespecified selection criteria. Disagreements were resolved by discussion with JL. The authors (YX and HL) were not blinded to the authors' names and institutions, journal of publication, or trial results. </p> </section> <section id="CD009004-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>Two authors (YX and HL) extracted data independently using a self‐developed data extraction form. Disagreements were resolved by discussion with JL. The following characteristics and data were extracted from each included trial. </p> <p> <ul id="CD009004-lst1-0005"> <li> <p>Methods: trial design, the information needed to assess the risk of bias domains (listed below), sample size calculations, and length of follow‐up. </p> </li> <li> <p>Participants: age, sex, ethnic origin, previous antiviral treatment, duration of hepatitis B, diagnostic criteria, inclusion and exclusion criteria, number of patients randomised, assessment of compliance, and withdrawals/losses to follow‐up (reasons/description). </p> </li> <li> <p>Interventions: species and origin of <i>phyllanthus</i>, dosage and duration of therapy, formulation, route of administration, and intervention in the control group. </p> </li> <li> <p>Outcomes: as listed above under outcome measures.</p> </li> </ul> </p> </section> <section id="CD009004-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (YX and HL) independently assessed the risk of bias for each included randomised trial. Disagreements were resolved by discussion with JL. We assessed the following domains (<a href="./references#CD009004-bbs2-0073" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. ">Schulz 1995</a>; <a href="./references#CD009004-bbs2-0064" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet1998;352(9128):609‐13. ">Moher 1998</a>; <a href="./references#CD009004-bbs2-0047" title="JüniP , AltmanDG , EggerM . Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ (Clinical Research Ed.)2001;323(7303):42‐6. ">Jüni 2001</a>; <a href="./references#CD009004-bbs2-0050" title="KjaergaardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomised trials in meta‐analyses. Annals of Internal Medicine2001;135(11):982‐9. ">Kjaergaard 2001</a>; <a href="./references#CD009004-bbs2-0083" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanGD , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ (Clinical Research Ed.)2008;336:601‐5. ">Wood 2008</a>; <a href="./references#CD009004-bbs2-0061" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>; <a href="./references#CD009004-bbs2-0070" title="SavovicJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment2012;16(35):1‐82. ">Savovic 2012a</a>; <a href="./references#CD009004-bbs2-0071" title="SavovicJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429‐38. ">Savovic 2012b</a>): </p> <p><i><b>Allocation sequence generation</b> </i> <br/> ‐ Low risk of bias: sequence generation was achieved using computer random number generation or a random number table. Drawing lots, tossing a coin, shuffling cards and throwing dice are adequate if performed by an independent adjudicator. <br/> ‐ Uncertain risk of bias: the trial is described as randomised, but the method of sequence generation was not specified. <br/> ‐ High risk of bias: the sequence generation method is not, or may not be, random. Quasi‐randomised studies, those using dates, names, or admittance numbers in order to allocate patients are inadequate and will be excluded for the assessment of benefits but not for harms. <br/> <br/> <i><b>Allocation concealment</b> </i> <br/> ‐ Low risk of bias: allocation was controlled by a central and independent randomisation unit, sequentially numbered, opaque and sealed envelopes or similar, so that intervention allocations could not have been foreseen in advance of, or during, enrolment. <br/> ‐ Uncertain risk of bias: the trial was described as randomised but the method used to conceal the allocation was not described, so that intervention allocations may have been foreseen in advance of, or during, enrolment. <br/> ‐ High risk of bias: if the allocation sequence was known to the investigators who assigned participants or if the study was quasi‐randomised. Quasi‐randomised studies will be excluded for the assessment of benefits but not for harms. <br/> <br/> <i><b>Blinding</b> </i> <br/> ‐ Low risk of bias: the trial was described as blinded, the parties that were blinded, and the method of blinding was described, so that knowledge of allocation was adequately prevented during the trial. <br/> ‐ Uncertain risk of bias: the trial was described as blind, but the method of blinding was not described, so that knowledge of allocation was possible during the trial. <br/> ‐ High risk of bias: the trial was not blinded, so that the allocation was known during the trial. <br/> <br/> <i><b>Incomplete outcome data</b> </i> <br/> ‐ Low risk of bias: the numbers and reasons for dropouts and withdrawals in all intervention groups were described or if it was specified that there were no dropouts or withdrawals. <br/> ‐ Uncertain risk of bias: the report gave the impression that there had been no dropouts or withdrawals, but this was not specifically stated. <br/> ‐ High risk of bias: the number or reasons for dropouts and withdrawals were not described. <br/> <br/> <i><b>Selective outcome reporting</b> </i> <br/> ‐ Low risk of bias: pre‐defined, or clinically relevant and reasonably expected outcomes are reported on. <br/> ‐ Uncertain risk of bias: not all pre‐defined, or clinically relevant and reasonably expected outcomes are reported on or are not reported fully, or it is unclear whether data on these outcomes were recorded or not. <br/> ‐ High risk of bias: one or more clinically relevant and reasonably expected outcomes were not reported on; data on these outcomes were likely to have been recorded. <br/> <br/> <i><b>Other biases</b> </i> <br/> ‐ Low risk of bias: the trial appears to be free of other sources of bias (eg, conflict of interest bias). <br/> ‐ Uncertain risk of bias: there is insufficient information to assess whether other sources of bias are present). <br/> ‐ High risk of bias: it is likely that potential sources of bias related to specific design used, early termination due to some data‐dependent process, lack of sample size or power calculation, or other bias risks are present. </p> <p>Authors' judgements were based on the definitions of the above listed domains, and trials with adequate assessments in all of the above mentioned bias risks domains were considered as having low risk of bias. Otherwise, a trial was considered with high risk of bias. </p> </section> <section id="CD009004-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data, such as mortality, we presented results as summary risk ratio (RR) with 95% confidence interval (CI). </p> </section> <section id="CD009004-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <p>Intervention groups of patients in randomised clinical trials. All trials included were with the parallel design. </p> </section> <section id="CD009004-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>We planned to seek missing data by contacting the trials’ authors. In case the data was still lacking, we put the trial to high risk of bias (missing outcomes) and conducted intention‐to‐treat analysis as well as sensitivity analysis (missing individuals). </p> </section> <section id="CD009004-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to use the chi‐square statistic to assess heterogeneity and I‐square statistic to measure inconsistency (<a href="./references#CD009004-bbs2-0044" title="HigginsJ , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Colloboration, 2009. Available from www.cochrane‐handbook.org. ">Higgins 2009</a>). </p> </section> <section id="CD009004-sec3-0014"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to use the funnel plot to investigate reporting biases if there were more than ten included trials. </p> </section> <section id="CD009004-sec3-0015"> <h4 class="title">Data synthesis</h4> <p><b>Meta‐analyses</b> <br/> For all analyses, we used the fixed‐effect model (<a href="./references#CD009004-bbs2-0037" title="DeMetsDL . Practical aspects in data monitoring: a brief review. Statistics in Medicine1987;6(7):753‐60. ">DeMets 1987</a>) as well as the random‐effects model meta‐analyses (<a href="./references#CD009004-bbs2-0038" title="DerSimonianR , LaidN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. [MEDLINE: 3802833] ">DerSimonian 1986</a>). In case there was no difference in statistical significance, we presented the results of the random‐effects analyses. Otherwise, we presented the results of both analyses. The analyses were carried out using the latest Cochrane Review Manager software (<a href="./references#CD009004-bbs2-0067" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>). </p> <p>Meta‐analysis is a summary intervention effect estimation based on a weighted average calculation of the intervention effects estimated in the individual trials. One cannot conduct a meta‐analysis if only one trial is identified. If only one trial assessed an outcome, we still presented the data in a forest plot in order to give a more complete overview, to prepare our review for future updates, and to obtain relative risks with confidence intervals. We are well aware that the relative risks and confidence intervals may not be fully correct. </p> <p><b>Trial sequential analysis (TSA)</b> <br/> We planned to perform trial sequential analysis (TSA) for all of the outcomes. Trial sequential analysis aims to reduce the risk of random error in the setting of sparse data and repetitive testing of accumulating data, thereby improving the reliability of conclusions (<a href="./references#CD009004-bbs2-0030" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61(8):763‐9. ">Brok 2008</a>; <a href="./references#CD009004-bbs2-0078" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. ">Wetterslev 2008</a>; <a href="./references#CD009004-bbs2-0079" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9:86. ">Wetterslev 2009</a>; <a href="./references#CD009004-bbs2-0036" title="Copenhagen Trial Unit. TSA ‐ Trial Sequential Analysis. http://ctu.dk/tsa/ (accessed 4 September 2012). ">CTU 2011</a>; <a href="./references#CD009004-bbs2-0076" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User manual forTrial Sequential Analysis (TSA). http://ctu.dk/tsa/files/tsa_manual.pdf 2011 (accessed 4 Spetember 2012). ">Thorlund 2011</a>). </p> <p>We planned to calculate the information size, providing an estimate of how many patients would be required in order to make a reliable conclusion. In our trial sequential analyses, the required information size was based on the proportion of patients with the outcome in the control group assumption of a plausible RR reduction of 10% or on the RR reduction observed in the included trials with low risk of bias, a type I error of 5%, and a type II error of 20% (<a href="./references#CD009004-bbs2-0078" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. ">Wetterslev 2008</a>). We planned to use control event rates from our own results to do these calculations. We adjusted the information size for diversity (<a href="./references#CD009004-bbs2-0079" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9:86. ">Wetterslev 2009</a>). </p> </section> <section id="CD009004-sec3-0016"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to conduct subgroup analyses to explore differences in trials with low risk of bias compared to trials with high risk of bias, among different species of <i>phyllanthus</i>, antiviral drugs, populations with different co‐infections, and diseases. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009004-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009004-sec1-0004"></div> <section id="CD009004-sec2-0008"> <h3 class="title">Description of studies</h3> <p>We identified a total of 212 publications through electronic searches and hand‐searching. We excluded 174 duplicates among databases, clearly irrelevant publications or non‐clinical studies. Thirty eight publications were retrieved for further assessment. Of these, we excluded 33 which are listed under '<a href="./references#CD009004-sec2-0016" title="">Characteristics of excluded studies</a>' with reasons for exclusion. Accordingly, five trials fulfilled our inclusion criteria and were included. For a summary of the search see <a href="#CD009004-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009004-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram of the search." data-id="CD009004-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram of the search.</p> </div> </div> </div> <p>The five randomised clinical trials were parallel group trials published as full articles. Three of the five included trials had three arms which were <i>phyllanthus</i> , antiviral drugs, and a combination of <i>phyllanthus</i> and antiviral drugs (<a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a>; <a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a>; <a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a>). The data from the two arms comparing <i>phyllanthus</i> alone versus antiviral drug alone were included in this review. </p> <p>Two hundred and ninety patients randomly allocated to <i>phyllanthus</i> versus antiviral drugs were included into analyses of our review. </p> <p>One trial included both in‐patients and out‐patients (<a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a>). One trial included out‐patients (<a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a>). The other three trials did not specify the origin of the patients (<a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a>; <a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a>; <a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a>). One trial included both children and adults (age ranging from 9 to 65 years) (<a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a>). The remaining four trials included only adults (age ranging from 15 to 59 years). All trials reported the male/female ratio. There were 72% males and 28% females. </p> <p>All trials reported that viral hepatitis diagnosed according to the National Conference on Infectious Disease or Viral Hepatitits in China. In the trial <a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a>, 37 patients out of 47 were HBeAg negative. In the trial <a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a>, 29 patients out of 55 were HBeAg negative. In the remaining trials all patients included were HBeAg positive. None of the trials reported any informations of patients with co‐infections or diseases. </p> <p>Patients in the experimental group of the five trials received compound <i>phyllanthus.</i> The antiviral drugs used in the control group were lamivudine, interferon alpha, thymosin, or thymosin alpha1. All the dosage and duration of the antiviral drugs were in accordance with standards of international guidelines. The treatment duration varied from three months to 12 months. Detailed information of the five randomised trials and the source and administration of <i>phyllanthus</i> species and antiviral drugs were summarised in <a href="#CD009004-tbl-0003">Table 1</a>, <a href="#CD009004-tbl-0004">Table 2</a>, and <a href="#CD009004-tbl-0005">Table 3</a>. </p> <div class="table" id="CD009004-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table 1: Random clinical trials of phyllanthus species</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>n</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean age</b> </p> <p><b>(years)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Male sex</b> </p> <p><b>(male)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>Phyllanthus</i> group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Length</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Post treatment / follow‐up</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 to 46</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> tablet </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 to 55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> capsule </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 to 55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> capsule </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interferon alpha 1 b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 to 65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> tablet </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 to 53</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> capsule </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin alpha 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009004-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table 2: Source and administration of compound phyllanthus</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Source and preparation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Species</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Part of the <i>phyllanthus</i> plant</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dose</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Length</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet, but no detail</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 6 tablets, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule, prepared by Institute of Tropical Medical preparation room of Guangzhou University of Traditional Chinese Medicine, other ingredients assumed to have no antiviral effects included Astragalus membranaceus, Panax Notoginseng, etc. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 capsules, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule, prepared by Institute of Tropical Medical preparation room of Guangzhou University of Traditional Chinese Medicine, other ingredients assumed to have no antiviral effects included Panax Notoginseng, etc. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 capsules, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet, produced by Pharmaceutical production in Dali, Yunnan province</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> urinaria L. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 tablets, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule, prepared by Institute of Tropical Medical preparation room of Guangzhou University of Traditional Chinese Medicine, other ingredients assumed to have no antiviral effects included Astragalus membranaceus, Panax Notoginseng, etc. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 capsules, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009004-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table 3: Administration of antiviral drugs</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Preparation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dose</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Length</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets, but no details</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg, po, qd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets, produced by GlaxoSmithKline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg, po, qd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interferon alpha 1 b, produced by Shanghai Institute of Biological Products</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300 IU, IM, qod</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin, but no details</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 mg, IM, qd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin alpha 1, produced by Hainan Shuangcheng Pharmaceutical Co. Ltd, powder formulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6 mg IM, twice a week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>po = orally; <br/> qd = every day; <br/> qod = every other day; <br/> tid = three times a day; <br/> IM = intramuscular. </p> </div> </div> <p>The outcome measures reported in the five trials were virological markers and/or biochemical variables. None of the trials reported mortality, hepatitis B‐related morbidity, liver histology progress, or quality of life. </p> <p>Further details are listed in the table of '<a href="./references#CD009004-sec2-0015" title="">Characteristics of included studies</a>'. </p> </section> <section id="CD009004-sec2-0009"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias of included trials is summarised in <a href="#CD009004-fig-0002">Figure 2</a> and <a href="#CD009004-fig-0003">Figure 3</a>. Following the risk of bias components, all trials included were classified as trials with high risk of bias. </p> <div class="figure" id="CD009004-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009004-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009004-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009004-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD009004-sec3-0017"> <h4 class="title">Allocation</h4> <p><b>Allocation sequence generation</b>  </p> <p>Generation of the allocation sequence was adequately reported in two trials (<a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a>; <a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a> ). In both trials, patients were randomised by Casio random number. </p> <p><b>Allocation concealment</b> </p> <p>Allocation concealment was not described in any of the trials.</p> </section> <section id="CD009004-sec3-0018"> <h4 class="title">Blinding</h4> <p>None of the trials actually stated that the patients were blinded to the intervention. As the different administration described between the intervention groups of the included trials, we considered that no blinding was performed in the five trials. </p> </section> <section id="CD009004-sec3-0019"> <h4 class="title">Incomplete outcome data</h4> <p>None of the five included trials reported if there were withdrawals or dropouts. The number of patients analysed were the same as the number of patients randomised. It seems unlikely that no patients drop out during the treatment (from three months to 12 months). However, we could not get confirmation on that as we were unable to contact the authors. </p> </section> <section id="CD009004-sec3-0020"> <h4 class="title">Selective reporting</h4> <p>In the five trials, none of the randomised patients were analysed for the primary outcomes chosen for this systematic review. As no contact information was given in the trials, we tried, but were not able to contact any of the authors of the included trials. Therefore, It is unclear whether the trial reported all the outcomes which had been measured. </p> </section> <section id="CD009004-sec3-0021"> <h4 class="title">Other potential sources of bias</h4> <p>None of the trials reported a sample size calculation. We also planned to assess publication bias using a funnel plot. We did not make this assessment due to the limited number of trials that were included. </p> </section> </section> <section id="CD009004-sec2-0010"> <h3 class="title" id="CD009004-sec2-0010">Effects of interventions</h3> <p><i><b>Mortality and morbidity</b> </i> </p> <p>None of the trials reported on mortality or morbidity.</p> <p><i><b>Adverse events</b> </i> </p> <p>Only one trial reported that adverse events were observed <a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a>. Data of adverse events were not reported. The type of adverse events reported in the trial was mild gastrointestinal symptoms. Joint pain, leukopenia and/or thrombocytopenia, depression, and poor sleep were reported in the lamivudine group. The trial reported that none of the patients who experienced these adverse events required dose modification, interruption or prolonged hospitalisation. </p> <p><i><b>Quality of life</b> </i> </p> <p>None of the trials reported on quality of life.</p> <p><i><b>Number of patients with detectable serum HBsAg</b> </i> </p> <p>Four trials provided data for serum HBsAg after treatment (<a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a>; <a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a>; <a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a>; <a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a>). The meta‐analysis showed no statistically significant difference between <i>phyllanthus</i> and antiviral drugs (RR 1.00; 95% CI 0.93 to 1.08, P = 0.92; I<sup>2</sup> = 0%). The antiviral drugs used in the five trials were lamivudine, interferon alpha, thymosin, or thymosin alpha 1. </p> <p>According to the subgroup analyses, there was no statistically significant difference of <i>phyllanthus</i> on clearance of serum HBsAg when compared with lamivudine (RR 1.04; 95% CI 0.89 to 1.21), interferon alpha (RR 1.01; 95% CI 0.87 to 1.18), or thymosin (RR 0.99; 95% CI 0.89 to 1.09, P = 0.79; I<sup>2</sup> = 0%). </p> <p><i><b>Number of patients with detectable serum HBV DNA</b> </i> </p> <p>Four trials reported data for serum HBV DNA after the end of treatment (<a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a>; <a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a>; <a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a>; <a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a>). Combining results of these five trials showed that there was no statistically significant difference between <i>phyllanthus</i> and antiviral drugs (RR 0.83; 95% CI 0.53 to 1.31, P = 0.43; I<sup>2</sup> = 70%). </p> <p>One trial also reported data after six months' post‐treatment follow‐up (<a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a>). There was no significant difference between <i>phyllanthus</i> and lamivudine on clearance of serum HBV DNA (RR 0.53; 95% CI 0.25 to 1.14). </p> <p>According to the subgroup analyses, <i>phyllanthus</i> showed no significant difference of effect on clearance of serum HBV DNA when tested against lamivudine (RR 0.87; 95% CI 0.21 to 3.57, P = 0.85; I<sup>2</sup> = 93%), interferon alpha (RR 1.17; 95% CI 0.61 to 2.24), or thymosin (RR 0.86; 95% CI 0.59 to 1.25). </p> <p><i><b>Number of patients with detectable serum HBeAg</b> </i> </p> <p>All of the five trials reported this outcome. Combining results of these trials showed that <i>phyllanthus</i> had a superior effect on clearance of serum HBeAg at the end of treatment between <i>phyllanthus</i> and antiviral drugs in traditional meta‐analysis (RR 0.76; 95% CI 0.64 to 0.91, P = 0.002; I<sup>2</sup> = 0%). </p> <p>However, trial sequential analysis on data for detectable serum HBeAg after treatment does not support a 10% relative risk reduction (RRR) in the <i>phyllanthus</i> group compared with antiviral drug group (<a href="#CD009004-fig-0004">Figure 4</a>). The required information size of 1574 was calculated based on a control event proportion of 75.8%, a relative risk reduction of 10%; a risk of type I error of 5%, a power of 80%, and a diversity of 30%. Although the cumulated Z‐curve (blue curve) crossed the traditional boundary of 5% significance (horizontal red line), it did not cross the trial sequential monitoring boundary (red curve), implying that firm evidence was not reached. </p> <div class="figure" id="CD009004-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Figure 4: Trial sequential analysis with a type 1 error of 5% on phyllanthus species versus antiviral drugs for patients with chronic hepatitis B on clearance of serum HBeAg. Trial sequential analysis of five trials (marked with black squares), illustrating that the cumulative Z‐curve (blue curve) did not cross the monitoring boundaries (red inward sloping curves), which is needed to obtain firm evidence controlling for the risk of random error. The required information size (RIS) is calculated to be 1574 patients (vertical line) based on a relative risk reduction (RRR) of 10%, event proportion of 75.8% in the control group (PC), type I error (α) of 5%, type II error (β) of 20%, and diversity (D) of 30%." data-id="CD009004-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Figure 4: Trial sequential analysis with a type 1 error of 5% on <i>phyllanthus</i> species versus antiviral drugs for patients with chronic hepatitis B on clearance of serum HBeAg. Trial sequential analysis of five trials (marked with black squares), illustrating that the cumulative Z‐curve (blue curve) did not cross the monitoring boundaries (red inward sloping curves), which is needed to obtain firm evidence controlling for the risk of random error. The required information size (RIS) is calculated to be 1574 patients (vertical line) based on a relative risk reduction (RRR) of 10%, event proportion of 75.8% in the control group (PC), type I error (α) of 5%, type II error (β) of 20%, and diversity (D) of 30%. </p> </div> </div> </div> <p>No statistically significant difference was seen after 6 months' post treatment follow‐up which was reported in the trial <a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a> (RR 0.70; 95% CI 0.26 to 1.88). </p> <p>According to the subgroup analyses, <i>phyllanthus</i> showed a better effect on clearance of serum HBeAg when tested against lamivudine (RR 0.68; 95% CI 0.53 to 0.87, P = 0.002; I<sup>2</sup> = 0%). <i>Phyllanthus</i> showed no significant difference when compared with interferon alpha (RR 1.05; 95% CI 0.63 to 1.76), or thymosin (RR 0.78; 95% CI 0.59 to 1.03, P = 0.08; I<sup>2</sup> = 0%). </p> <p><i><b>Number of participants without HBeAg seroconversion</b> </i> </p> <p>Only one trial reported data for HBeAg seroconversion <a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a>. <i>Phyllanthus</i> showed no significant difference of effect on HBeAg seroconversion when tested against lamivudine at the end of treatment (RR 0.89; 95% CI 0.71 to 1.11). </p> <p><i><b>Number of participants with worsened liver histology</b> </i> </p> <p>None of the trials reported data on this outcome measure.</p> <p><b>Subgroup analyses</b> </p> <p>All of our meta‐analyses were based on five trials and all of the trials were with high risk of bias. Based on the information given in the trials, we were only able to perform subgroup analyses according to different antiviral drugs used in the control groups. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009004-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009004-sec1-0005"></div> <section id="CD009004-sec2-0011"> <h3 class="title" id="CD009004-sec2-0011">Summary of main results</h3> <p>There was no convincing evidence that <i>phyllanthus</i> was superior compared with antiviral drugs regarding virological outcomes. It would take much more patients to prove equivalence or non‐inferiority. Based on the present findings as well as the findings in our previous review assessing <i>phyllanthus</i> versus placebo or no intervention, we conclude that there is currently no evidence to support or refute the use of <i>phyllanthus</i> species for patients with chronic hepatitis B. </p> <p>For the primary outcomes chosen in our review, no data were identified from the five trials. With regard to potential adverse events, there was only one trial reporting on this outcome. Only the type of adverse events were reported in that trial and no patients required dose modification, interruption or prolonged hospitalisation. However, insufficient evidence for adverse events of <i>phyllanthus</i> from randomised trials cannot lead to the conclusion that <i>phyllanthus</i> does not cause harm. </p> <p>For the secondary outcomes, there was only one outcome for which traditional meta‐analysis revealed a statistically significant benefit in the <i>phyllanthus</i> group. The clearance of serum HBeAg for which the results from five trials showed a RR (risk ratio) of 0.76 (95% CI 0.64 to 0.91). However, the trial sequential analysis does not support the finding from the traditional meta‐analysis, implying that firm evidence was not reached. In addition, there are four things we should keep in mind. First, this potential benefit is on an outcome which is only a putative surrogate outcome (<a href="./references#CD009004-bbs2-0041" title="GluudC , BrokJ , GongY , KoretzR . Hepatology may have problems with putative surrogate outcome measures. Journal of Hepatology2007;46:734‐42. ">Gluud 2007</a>). Second, our systematic review has a major limitation which is a small number of trials included. This increases the risks of random errors. In accordance, trial sequential analysis suggested that the observed intervention effect could be due to random error. Fourth, all of the five trials were considered to have high risk of bias. This increases the risk of systematic errors. </p> <p>For the other five secondary outcomes, meta‐analyses showed no statistically significant differences between <i>phyllanthus</i> and antiviral drug groups. However, the fact that we did not find significant differences between <i>phyllanthus</i> compared with antiviral drugs cannot be taken as evidence that <i>phyllanthus</i> does work. First, we have been unable to find high quality evidence from randomised clinical trials supporting <i>phyllanthus</i> versus placebo or no intervention (<a href="./references#CD009004-bbs2-0084" title="XiaY , LuoH , LiuJP , GluudC . Phyllanthus species for chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews2011, Issue 4. [DOI: 10.1002/14651858.CD008960.pub2] ">Xia 2011</a>). Second, the fact that we observed no difference between <i>phyllanthus</i> versus antiviral drugs does not suggest activity of the former. The trials are too small to exclude a difference. Moreover, the trials of the present review had high risk of bias. </p> <p>With regard to the treatments used in the control groups, the adequacy of the treatments need to be evaluated. The evidence of the use of lamivudine and interferon alpha has been elaborated in the section of ‘<a href="#CD009004-sec2-0002">Description of the intervention</a>’ in the background. For the use of thymosin, a controlled, blinded study suggested that thymosin might be effective on clearance of the HBV virus for patients with chronic active hepatitis B virus infection (<a href="./references#CD009004-bbs2-0065" title="MutchnickMG , AppelmanHD , ChungHT , AragonaE , GuptaTP , CummingsGD , et al. Thymosin treatment of chronic hepatitis B: a placebo‐controlled pilot trial. Hepatology1991;14(3):409‐15. ">Mutchnick 1988</a>). Thymosin alpha 1, a biologically active peptide isolated from thymosin fraction 5 (TF5) which is a partially purified extract of bovine thymus, is one of the first‐line drugs recommended by APASL (Asian Pacific Association for the Study of Liver) for treating chronic hepatitis B (<a href="./references#CD009004-bbs2-0054" title="LiawYF , LeungN , GuanR , LauGK , MericanI . Asian‐Pacific consensus statement on the management of chronic hepatitis B: an update. Journal of Gastroenterol Hepatology2003;18(3):239‐45. ">Liaw 2003</a>; <a href="./references#CD009004-bbs2-0055" title="LiawYF , LeungN , GuanR , LauGK , MericanI , McCaughanG , et al. Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver International2005;25(3):472‐89. ">Liaw 2005</a>; <a href="./references#CD009004-bbs2-0056" title="LiawYF , LeungN , KaoJH , PiratvisuthT , GaneE , HanKH , et al. Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatology International2008;2(3):263‐83. ">Liaw 2008</a>). Now thymosin alpha 1 has been approved in 35 countries for the treatment of chronic hepatitis B (<a href="./references#CD009004-bbs2-0040" title="GaraciE , FavalliC , PicaF , Sinibaldi VallebonaP , PalamaraAT , MatteucciC . Thymosin alpha 1: from bench to bedside. The New York Academy of Sciences2007;1112:225‐34. ">Garaci 2007</a>; <a href="./references#CD009004-bbs2-0043" title="GoldsteinAL , GoldsteinAL . From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opinion on Biological Therapy2009;9(5):593‐608. ">Goldstein 2009</a>). However, this approval has not been given to other thymosin products (<a href="./references#CD009004-bbs2-0057" title="LinL , LinJW . Advance in research on the thymosin preparation. Chinese Pharmaceutical Affairs2009;23(7):706‐10. ">Lin 2009</a>). In China, thymosin products have been used in clinical practice as antiviral agents for more than 20 years (<a href="./references#CD009004-bbs2-0057" title="LinL , LinJW . Advance in research on the thymosin preparation. Chinese Pharmaceutical Affairs2009;23(7):706‐10. ">Lin 2009</a>) and the Guideline of Prevention and Treatment of Chronic Hepatitis B published in 2005 in China explicitly approved the usage of thymosin alpha 1 (<a href="./references#CD009004-bbs2-0035" title="Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The Guideline of Prevention and Treatment of Chronic Hepatitis B. Chinese Journal of Hepatology2005;12:1. ">Chinese guideline on chronic hepatitis B 2005</a>). One protocol of Cochrane systematic review was identified to evaluate the beneficial and harmful effects of thymosin alpha 1 (<a href="./references#CD009004-bbs2-0069" title="SaconatoH , AtallahÁN , SouzaGM , PariseER . Thymosin alpha1 for chronic hepatitis B. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003621] ">Saconato 2009</a>), however, the full review has not been finished yet. Therefore, convincing evidence of thymosin alpha 1 or other thymosin products is still needed. </p> <p>There might be biases in the process of our review. Although we made extensive searches, only five trials were identified. We may still have missed potentially eligible trials which were published in a particular language or indexed in databases which are not accessible. This precludes exploration of reporting bias. All the five trials were conducted in China and all the patients included were Chinese. Accordingly, the findings from our review may not apply to other populations. In addition, our review researchers were not blinded to the authors of the included trials. </p> <p>A systematic review of genus <i>phyllanthus</i> for chronic hepatitis B virus infection was published in 2001 (<a href="./references#CD009004-bbs2-0059" title="LiuJP , LinH , McIntoshH . Genus Phyllanthus for chronic hepatitis B virus infections: a systematic review. Journal of Viral Hepatitis2001;8:358‐66. ">Liu 2001</a>), in which <i>phyllanthus</i> was compared with placebo, no intervention, general nonspecific treatment, other herbal medicine, or interferon treatment for patients with chronic hepatitis B and chronic hepatitis B carriers. In that review, no robust conclusion could be drawn for the use of genus <i>phyllanthus</i> due to the low methodological quality of included trials and the variations of the herb. In our present review, trials testing <i>phyllanthus</i> in chronic hepatitis B carriers were not included, and <i>phyllanthus</i> were compared only with antiviral drugs. But our results as well as recommendations are basically in accordance with the former systematic review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009004-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram of the search." data-id="CD009004-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram of the search.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009004-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009004-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Figure 4: Trial sequential analysis with a type 1 error of 5% on phyllanthus species versus antiviral drugs for patients with chronic hepatitis B on clearance of serum HBeAg. Trial sequential analysis of five trials (marked with black squares), illustrating that the cumulative Z‐curve (blue curve) did not cross the monitoring boundaries (red inward sloping curves), which is needed to obtain firm evidence controlling for the risk of random error. The required information size (RIS) is calculated to be 1574 patients (vertical line) based on a relative risk reduction (RRR) of 10%, event proportion of 75.8% in the control group (PC), type I error (α) of 5%, type II error (β) of 20%, and diversity (D) of 30%." data-id="CD009004-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Figure 4: Trial sequential analysis with a type 1 error of 5% on <i>phyllanthus</i> species versus antiviral drugs for patients with chronic hepatitis B on clearance of serum HBeAg. Trial sequential analysis of five trials (marked with black squares), illustrating that the cumulative Z‐curve (blue curve) did not cross the monitoring boundaries (red inward sloping curves), which is needed to obtain firm evidence controlling for the risk of random error. The required information size (RIS) is calculated to be 1574 patients (vertical line) based on a relative risk reduction (RRR) of 10%, event proportion of 75.8% in the control group (PC), type I error (α) of 5%, type II error (β) of 20%, and diversity (D) of 30%. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Phyllanthus versus antiviral drug, Outcome 1 Number of patients with detectable serum HBsAg." data-id="CD009004-fig-00101" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Phyllanthus versus antiviral drug, Outcome 1 Number of patients with detectable serum HBsAg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Phyllanthus versus antiviral drug, Outcome 2 Number of patients with detectable serum HBV DNA ( end of treatment )." data-id="CD009004-fig-00102" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Phyllanthus versus antiviral drug, Outcome 2 Number of patients with detectable serum HBV DNA ( end of treatment ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Phyllanthus versus antiviral drug, Outcome 3 Number of patients with detectable serum HBV DNA ( end of post‐treatment follow‐up )." data-id="CD009004-fig-00103" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Phyllanthus versus antiviral drug, Outcome 3 Number of patients with detectable serum HBV DNA ( end of post‐treatment follow‐up ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Phyllanthus versus antiviral drug, Outcome 4 Number of patients with detectable serum HBeAg ( end of treatment )." data-id="CD009004-fig-00104" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Phyllanthus versus antiviral drug, Outcome 4 Number of patients with detectable serum HBeAg ( end of treatment ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Phyllanthus versus antiviral drug, Outcome 5 Number of patients with detectable serum HBeAg ( end of post‐treatment follow‐up )." data-id="CD009004-fig-00105" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Phyllanthus versus antiviral drug, Outcome 5 Number of patients with detectable serum HBeAg ( end of post‐treatment follow‐up ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Phyllanthus versus antiviral drug, Outcome 6 Number of patients without HBeAg seroconversion ( end of treatment )." data-id="CD009004-fig-00106" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Phyllanthus versus antiviral drug, Outcome 6 Number of patients without HBeAg seroconversion ( end of treatment ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 1 Number of patients with detectable serum HBsAg." data-id="CD009004-fig-00201" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 1 Number of patients with detectable serum HBsAg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 2 Number of patients with detectable serum HBV DNA ( end of treatment )." data-id="CD009004-fig-00202" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 2 Number of patients with detectable serum HBV DNA ( end of treatment ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 3 Number of patients with detectable serum HBeAg ( end of treatment )." data-id="CD009004-fig-00203" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 3 Number of patients with detectable serum HBeAg ( end of treatment ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009004-fig-00204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/urn:x-wiley:14651858:media:CD009004:CD009004-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_t/tCD009004-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 4 Number of patients without HBeAg seroconversion (end of treatment)." data-id="CD009004-fig-00204" src="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Phyllanthus versus antiviral drug according to antiviral drugs, Outcome 4 Number of patients without HBeAg seroconversion (end of treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-fig-00204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/media/CDSR/CD009004/image_n/nCD009004-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009004-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table 1: Random clinical trials of phyllanthus species</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>n</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean age</b> </p> <p><b>(years)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Male sex</b> </p> <p><b>(male)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>Phyllanthus</i> group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Length</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Post treatment / follow‐up</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 to 46</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> tablet </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 to 55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> capsule </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 to 55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> capsule </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interferon alpha 1 b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 to 65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> tablet </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 to 53</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83%</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> capsule </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin alpha 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table 1: Random clinical trials of phyllanthus species</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009004-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table 2: Source and administration of compound phyllanthus</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Source and preparation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Species</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Part of the <i>phyllanthus</i> plant</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dose</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Length</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet, but no detail</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 6 tablets, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule, prepared by Institute of Tropical Medical preparation room of Guangzhou University of Traditional Chinese Medicine, other ingredients assumed to have no antiviral effects included Astragalus membranaceus, Panax Notoginseng, etc. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 capsules, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule, prepared by Institute of Tropical Medical preparation room of Guangzhou University of Traditional Chinese Medicine, other ingredients assumed to have no antiviral effects included Panax Notoginseng, etc. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 capsules, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet, produced by Pharmaceutical production in Dali, Yunnan province</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Phyllanthus</i> urinaria L. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 tablets, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule, prepared by Institute of Tropical Medical preparation room of Guangzhou University of Traditional Chinese Medicine, other ingredients assumed to have no antiviral effects included Astragalus membranaceus, Panax Notoginseng, etc. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 capsules, po, tid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table 2: Source and administration of compound phyllanthus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009004-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table 3: Administration of antiviral drugs</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Preparation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dose</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Length</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0001" title="GeX , SongWL , HengSX , YangWD . Therapeutic effect observation of phyllanthus tablet for patients with lamivudine resistant hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases2005;15(1):50‐2. ">Ge 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets, but no details</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg, po, qd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0002" title="HuangZC , ZhuBX , ZhengQJ , YangSL , TanB , HeJY , et al. A comparative study on phyllanthus compound and lamivudine in the treatment of chronic hepatitis B. Journal of Guangzhou University of Traditional Chinese Medicine2004;21(3):161‐‐3. ">Huang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lamivudine tablets, produced by GlaxoSmithKline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 mg, po, qd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0003" title="LiCQ , WangXH , LiGQ , FangHX . Clinical observation of compound phyllanthus for patients with chronic hepatitis B. Journal of New Chinese Medicine1998;30(6):45‐6. ">Li 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interferon alpha 1 b, produced by Shanghai Institute of Biological Products</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300 IU, IM, qod</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0004" title="OuyangL . Thymosin and phyllanthus tablets for chronic hepatitis B in 42 cases. Chinese Journal of Traditional and Western Medicine on Liver Disease1999;9(5):44. ">Ouyang 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin, but no details</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 mg, IM, qd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009004-bbs2-0005" title="ZhuYC . Therapeutic effect observation of compound phyllanthus and thymosin alpha 1 for chronic hepatitis B. Anti Infection Pharmacy2005;2(4):165‐6. ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thymosin alpha 1, produced by Hainan Shuangcheng Pharmaceutical Co. Ltd, powder formulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6 mg IM, twice a week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>po = orally; <br/> qd = every day; <br/> qod = every other day; <br/> tid = three times a day; <br/> IM = intramuscular. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table 3: Administration of antiviral drugs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/full#CD009004-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009004-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Phyllanthus versus antiviral drug</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of patients with detectable serum HBsAg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.93, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of patients with detectable serum HBV DNA ( end of treatment ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.53, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of patients with detectable serum HBV DNA ( end of post‐treatment follow‐up ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.25, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of patients with detectable serum HBeAg ( end of treatment ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.63, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of patients with detectable serum HBeAg ( end of post‐treatment follow‐up ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.7 [0.26, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of patients without HBeAg seroconversion ( end of treatment ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Phyllanthus versus antiviral drug</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009004-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Phyllanthus versus antiviral drug according to antiviral drugs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of patients with detectable serum HBsAg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.93, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Phyllanthus versus lamivudine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.89, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Phyllanthus versus interferon alpha</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.87, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Phyllanthus versus thymosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.89, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of patients with detectable serum HBV DNA ( end of treatment ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.52, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Phyllanthus versus lamivudine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.21, 3.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Phyllanthus versus interferon alpha</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.61, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Phyllanthus versus thymosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.59, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of patients with detectable serum HBeAg ( end of treatment ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.63, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Phyllanthus versus lamivudine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.53, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Phyllanthus versus interferon alpha</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.63, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Phyllanthus versus thymosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.58, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of patients without HBeAg seroconversion (end of treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Phyllanthus versus lamivudine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.11]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Phyllanthus versus antiviral drug according to antiviral drugs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009004.pub2/references#CD009004-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009004.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009004-note-1207">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD009004-note-1206">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD009004-note-1205">日本語</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009004\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009004\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009004\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009004\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009004\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009004.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009004.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009004.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009004.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009004.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725057015"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009004.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725057020"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009004.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e71efe8e21bdf',t:'MTc0MDcyNTA1Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 